Innovative private company with patented nucleic acid technologies that have the potential to transform the clinicaland molecular diagnostics markets by enabling early and personalized diagnoses that guide treatment decisions.

DiamiR Biosciences is focused on the development and commercialization of an innovative technology based on analysis of brain-enriched microRNA biomarkers in blood plasma to be used for screening, early and differential diagnosis, enrollment of better defined participants into clinical trials, as well as disease progression and treatment monitoring.

CEO360 is an amazing, moderated peer-to-peer advisory program where 20-25 Life Sciences CEOs meet monthly and collaborate to solve their toughest business issues. Each CEO works on their specific issues, and are held accountable for progress. Unlike other groups run by business coaches, CEO360 focuses only on CEOs in the Life Sciences ecosystem. CEO360 was created by the leading Life Science professional firms to help the Life Sciences ecosystem thrive.

Inceptor Bio is developing multiple next-generation cell therapy platforms to cure difficult-to-treat cancers with a focus on novel mechanisms to enhance immune cell performance in the tumor microenvironment.

One of the spokes to Inceptor Bio, looking at novel CAR-T therapy applications

Shoe box sized, POC PCR device, able to produce lab quality results in 15mins

Novel molecular diagnostic company developing new tools for cUTI and antibiotic resistance. Hired on to develop commercial strategy and update business plan.

Pre start-up molecular diagnostic company looking for assistance in raising capital.Hired a small executive team and successfully finalized a term sheet for $7M. Pre-determined relocation of company to the east coast.

A young, dynamic and creative molecular diagnostics company. We have specialized in simple and rapid solutions for the diagnosis of severe infectious diseases in hospitalized patients. We help to combat infections effectively and detect antibiotic resistance at an early stage. Had additional responsibility with our parent group as EVP of WW Sales

One of four managing directors representing Curetis Group of the Curetis N.V.

Responsible for sales, marketing and commercial operations group based in Germany. Included 13 distributors worldwide.

Epic Sciences provides testing on non-invasive liquid biopsies that are incorporated into clinical trials for patient stratification, pharmacodynamics readouts, and to determine the mechanism of action and developing resistance to therapies. Additionally, the technology is compatible with downstream molecular characterization including protein, FISH, NGS and other genomic assays.

Metabolon is the industry leader in Metabolomics technology. This solution based technology leaps beyond genomics and proteomics to uncover changes at the molecular level. We are rapidly expanding our commecial services model as well as laying the necessary market ground work for our diagnostic products. With an extremely strong patent position, Metabolon looks to continue to penetrate into the commercial, academic and consumer goods arenas. Had global responsibility for sales, marketing and sales operations.

Abaxis manufacturers the only waived, POC, chemistry analyzer on the market. From Nov. 2005 to Mar. 2009 we built a point of care sales, marketing, customer service and tech service teams and used distribution partners to grow piccolo sales 83% over four years and drive placements from 116 to over 1,500 customers. The market included all physician office specialties as well as urgent care, oncology treatment facilities and hospitals. Abaxis will need to decide on a direct or distribution model future forward in order to maximize market penetration.

I held various sales and sales management roles at Cytyc Corp, now Hologic, over a ten year career. I spent the last 5 years as one of (5) Regional Business Directors (west).